Bullet Biotechnology is an innovative biotech company developing powerful products which will train a patient's own immune system to fight disease. Our capsid platform can be used to create powerful vaccines, with targeting (antigens) and immune stimulation (adjuvants) all covalently linked together in one product. We are also exploring the use of our capsid in developing other combination immunotherapies, including multi-specific antibodies and checkpoint inhibitors. Bullet Bio's experienced management team is taking a practical approach to building and realizing value for patients and investors.For additional information, please contact Bullet Bio at info@bulletbio.com.